Dr Reddys Laboratories RDY
NYSE RDY
$11.86 -0.02 (-0.13%)
As of: Sep 9, 2026 · 3:12 PM EDT

Dr Reddys Laboratories (RDY) Change in Inventory (2009 - 2026)

Dr Reddys Laboratories (RDY) posted Change in Inventory of -$76.7 million for Q2 2026, down 228.53% on a QoQ basis from -$23.3 million in Q3 2025, and down 6.71% year-over-year from -$82.2 million in Q2 2025.

Analysis

Dr Reddys Laboratories (RDY) Change in Inventory (2009 - 2026) Analysis & Trends

Dr Reddys Laboratories has reported Change in Inventory for 17 years, with the latest figure at -$76.7 million in Q2 2026.

  • On a quarterly basis, Change in Inventory fell 6.71% year-over-year to -$76.7 million in Q2 2026; TTM through Jun 2026 was -$231.7 million, a 8.94% increase from a year earlier, with the FY2026 full-year figure at -$92.0 million, up 38.26% from the prior year.
  • Change in Inventory was -$76.7 million for Q2 2026 at Dr Reddys Laboratories, down from -$23.3 million in the prior quarter.
  • The five-year high for Change in Inventory was $15.9 million in Q3 2022, with the low at -$188.5 million in Q1 2022.
  • Average Change in Inventory over 5 years is -$53.7 million, with a median of -$56.7 million recorded in 2023.
  • The sharpest annual moves came in 2023 and 2024: Change in Inventory jumped 99.22% in 2023, then plunged 3092.11% in 2024.
  • Over 5 years, Change in Inventory stood at -$20.0 million in 2022, then tumbled by 212.26% to -$62.5 million in 2023, then climbed by 4.31% to -$59.8 million in 2024, then jumped by 60.96% to -$23.3 million in 2025, then slumped by 228.53% to -$76.7 million in 2026.
  • The last three Change in Inventory figures came in at -$76.7 million (Q2 2026), -$23.3 million (Q3 2025), and -$71.9 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Teva Pharmaceutical Industries 42.55 Bn 38.89 Bn 2.15 Bn -59.00 Mn
2 Viatris 19.15 Bn 18.26 Bn 1.46 Bn 99.50 Mn
3 Dr Reddys Laboratories 9.87 Bn 9.70 Bn 396.53 Mn -76.69 Mn
4 Amneal Pharmaceuticals 5.45 Bn 5.32 Bn 334.51 Mn 69.19 Mn
5 Bausch Health Companies 2.33 Bn 492.63 Mn 2.10 Bn 22.00 Mn
6 Alvotech 1.51 Bn 1.36 Bn 2.56 Mn -403,000.00
7 Ani Pharmaceuticals 1.48 Bn 1.12 Bn 165.89 Mn -305,000.00
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn 9.88 Mn
9 Fennec Pharmaceuticals 401.76 Mn 360.51 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -76.69 Mn
Sep 30, 2025 -23.34 Mn
Jun 30, 2025 -71.86 Mn
Sep 30, 2024 -59.79 Mn
Jun 30, 2024 -75.80 Mn
Mar 31, 2024 -46.99 Mn
Dec 31, 2023 -62.49 Mn
Sep 30, 2023 -56.88 Mn
Jun 30, 2023 -56.45 Mn
Mar 31, 2023 -1.47 Mn
Dec 31, 2022 -20.01 Mn
Sep 30, 2022 15.87 Mn
Jun 30, 2022 -27.95 Mn
Mar 31, 2022 -188.51 Mn
Dec 31, 2021 114.13 Mn
Sep 30, 2021 14.45 Mn
Jun 30, 2021 -72.68 Mn
Mar 31, 2021 -49.72 Mn
Dec 31, 2020 -42.99 Mn
Sep 30, 2020 -26.22 Mn